120 related articles for article (PubMed ID: 19935403)
1. Zonisamide-induced weight loss in schizophrenia: case series.
Yang J; Lee MS; Joe SH; Jung IK; Kim SH
Clin Neuropharmacol; 2010; 33(2):104-6. PubMed ID: 19935403
[TBL] [Abstract][Full Text] [Related]
2. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-associated weight loss.
Hanwella R; de Silva V; Wijeratne C; Ketharanathan T; de Silva J
J Psychopharmacol; 2010 Jul; 24(7):1127-9. PubMed ID: 19264815
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
5. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
6. [Successful quetiapine therapy in psychotic patients with mood elevation].
Kecskés I
Neuropsychopharmacol Hung; 2009 Dec; 11(4):259-63. PubMed ID: 20150663
[TBL] [Abstract][Full Text] [Related]
7. Importance of oral glucose tolerance test in patient with schizophrenia.
Margetić B; Aukst-Margetić B; Badanjak A
Psychiatr Danub; 2005 Jun; 17(1-2):94-6. PubMed ID: 16395850
[TBL] [Abstract][Full Text] [Related]
8. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
[TBL] [Abstract][Full Text] [Related]
9. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia.
Kim E; Park DW; Choi SH; Kim JJ; Cho HS
J Clin Psychopharmacol; 2008 Apr; 28(2):138-46. PubMed ID: 18344723
[TBL] [Abstract][Full Text] [Related]
10. The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.
Ghanizadeh A; Nikseresht MS; Sahraian A
Schizophr Res; 2013 Jun; 147(1):110-115. PubMed ID: 23583010
[TBL] [Abstract][Full Text] [Related]
11. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
12. Memantine-associated reversal of clozapine-induced weight gain.
Schaefer M; Leopold K; Hinzpeter A; Heinz A; Krebs M
Pharmacopsychiatry; 2007 Jul; 40(4):149-51. PubMed ID: 17694477
[TBL] [Abstract][Full Text] [Related]
13. The clinical implications of weight gain in schizophrenia.
Kurzthaler I; Fleischhacker WW
J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.
McElroy SL; Winstanley E; Mori N; Martens B; McCoy J; Moeller D; Guerdjikova AI; Keck PE
J Clin Psychopharmacol; 2012 Apr; 32(2):165-72. PubMed ID: 22367654
[TBL] [Abstract][Full Text] [Related]
15. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
[TBL] [Abstract][Full Text] [Related]
16. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
17. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
[TBL] [Abstract][Full Text] [Related]
18. Clozapine-induced tardive dyskinesia: a case report.
Ertugrul A; Demir B
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
[TBL] [Abstract][Full Text] [Related]
19. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Zink M; Knopf U; Henn FA; Thome J
Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
[TBL] [Abstract][Full Text] [Related]
20. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
Huang TL; Lu CY
Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
